Phathom Pharmaceuticals (PHAT) Other Gross PP&E Adjustments (2022 - 2025)
Historic Other Gross PP&E Adjustments for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to -$3.0 million.
- Phathom Pharmaceuticals' Other Gross PP&E Adjustments fell 24722.63% to -$3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.0 million, marking a year-over-year decrease of 24722.63%. This contributed to the annual value of $2.5 million for FY2024, which is 16437.63% up from last year.
- Per Phathom Pharmaceuticals' latest filing, its Other Gross PP&E Adjustments stood at -$3.0 million for Q3 2025, which was down 24722.63% from -$1.0 million recorded in Q2 2025.
- In the past 5 years, Phathom Pharmaceuticals' Other Gross PP&E Adjustments registered a high of $2.5 million during Q4 2024, and its lowest value of -$4.8 million during Q2 2022.
- Moreover, its 4-year median value for Other Gross PP&E Adjustments was -$1.0 million (2025), whereas its average is -$854666.7.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first surged by 39607.56% in 2024, then tumbled by 24722.63% in 2025.
- Phathom Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at -$2.6 million in 2022, then surged by 136.26% to $946000.0 in 2023, then soared by 164.38% to $2.5 million in 2024, then plummeted by 219.91% to -$3.0 million in 2025.
- Its Other Gross PP&E Adjustments was -$3.0 million in Q3 2025, compared to -$1.0 million in Q2 2025 and -$1.0 million in Q1 2025.